ProShares Ultra Nasdaq BiotechnologyProShares Ultra Nasdaq BiotechnologyProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology

No trades
See on Supercharts

ProShares Ultra Nasdaq Biotechnology holdings


As of July 25, 2025
Symbol
Weight %
Shares
Market value
U
U.S. Dollar
26.27%
‪‪13.97 M‬‬
‪‪13.97 M‬‬USD
U
US912797MG9United States Treasury Bills 0.0% 07-AUG-2025
7.51%
‪‪4.00 M‬‬
‪‪4.00 M‬‬USD
A
AMGNAmgen Inc.
5.10%
‪‪8.84 K‬‬
‪‪2.71 M‬‬USD
V
VRTXVertex Pharmaceuticals Incorporated
5.09%
‪‪5.76 K‬‬
‪‪2.71 M‬‬USD
G
GILDGilead Sciences, Inc.
5.06%
‪‪23.15 K‬‬
‪‪2.69 M‬‬USD
R
REGNRegeneron Pharmaceuticals, Inc.
4.10%
‪‪3.87 K‬‬
‪‪2.18 M‬‬USD
A
AZNAstraZeneca PLC Sponsored ADR
2.97%
‪‪21.75 K‬‬
‪‪1.58 M‬‬USD
A
ALNYAlnylam Pharmaceuticals, Inc
2.59%
‪‪4.18 K‬‬
‪‪1.38 M‬‬USD
S
SMMTSummit Therapeutics Inc
1.47%
‪‪27.35 K‬‬
‪‪784.21 K‬‬USD
B
BIIBBiogen Inc.
1.33%
‪‪5.40 K‬‬
‪‪709.68 K‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.